Cross Country Healthcare Files 8-K

Ticker: CCRN · Form: 8-K · Filed: 2024-10-18T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 8-k, regulation-fd

Related Tickers: CCRN

TL;DR

CCRN filed a routine 8-K, no major news.

AI Summary

Cross Country Healthcare, Inc. filed an 8-K on October 18, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.

Why It Matters

This filing indicates that Cross Country Healthcare is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not disclose any new material events or financial information that would indicate increased risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits, as per SEC requirements.

What is the exact date of the report?

The date of the report is October 18, 2024.

What is the company's principal executive office address?

The company's principal executive office is located at 6551 Park of Commerce Boulevard, N.W., Boca Raton, FL 33487.

What is the company's IRS Employer Identification Number?

The company's IRS Employer Identification Number is 13-4066229.

Does this filing announce any new material events or financial results?

Based on the provided text, this filing appears to be a routine report and does not explicitly announce any new material events or specific financial results beyond standard disclosures.

From the Filing

0001628280-24-043116.txt : 20241018 0001628280-24-043116.hdr.sgml : 20241018 20241018162703 ACCESSION NUMBER: 0001628280-24-043116 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241018 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241018 DATE AS OF CHANGE: 20241018 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 241381041 BUSINESS ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 8-K 1 ccrn-20241018.htm 8-K ccrn-20241018 0001141103 FALSE 0001141103 2024-10-18 2024-10-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 18, 2024 Cross Country Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 0-33169 13-4066229 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6551 Park of Commerce Boulevard, N.W. , Boca Raton , FL 33487 (Address of Principal Executive Office) (Zip Code) ( 561 ) 998-2232 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act:     Title of each class                 Trading Symbol         Name of each exchange on which registered Common stock, par value $0.0001 per share          CCRN              The Nasdaq Stock Market LLC Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01    Regulation FD Disclosure. On October 18, 2024, the Company issued a press release, a copy of which is furnished herewith as Exhibit 99.1. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8

View on Read The Filing